Cargando…

Role of the microbiome in occurrence, development and treatment of pancreatic cancer

Pancreatic cancer is one of the most lethal malignancies. Recent studies indicated that development of pancreatic cancer may be intimately connected with the microbiome. In this review, we discuss the mechanisms through which microbiomes affect the development of pancreatic cancer, including inflamm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yicheng, Yang, Gang, You, Lei, Yang, Jinshou, Feng, Mengyu, Qiu, Jiangdong, Zhao, Fangyu, Liu, Yueze, Cao, Zhe, Zheng, Lianfang, Zhang, Taiping, Zhao, Yupei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885316/ https://www.ncbi.nlm.nih.gov/pubmed/31785619 http://dx.doi.org/10.1186/s12943-019-1103-2

Ejemplares similares

Expression, function and clinical application of stanniocalcin‐1 in cancer
por: Zhao, Fangyu, et al.
Publicado: (2020)

Novel discoveries targeting gemcitabine‐based chemoresistance and new therapies in pancreatic cancer: How far are we from the destination?
por: Luo, Wenhao, et al.
Publicado: (2019)

Extracellular vesicles as mediators of the progression and chemoresistance of pancreatic cancer and their potential clinical applications
por: Qiu, Jiangdong, et al.
Publicado: (2018)

Novel therapeutic strategies and perspectives for metastatic pancreatic cancer: vaccine therapy is more than just a theory
por: Luo, Wenhao, et al.
Publicado: (2020)

LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer
por: Feng, Mengyu, et al.
Publicado: (2018)

Novel Discoveries Targeting Pathogenic Gut Microbes and New Therapies in Pancreatic Cancer: Does Pathogenic E. coli Infection Cause Pancreatic Cancer Progression Modulated by TUBB/Rho/ROCK Signaling Pathway? A Bioinformatic Analysis
por: Luo, Wenhao, et al.
Publicado: (2020)

Comprehensive Analysis of Autophagy-Associated lncRNAs Reveal Potential Prognostic Prediction in Pancreatic Cancer
por: Chen, Guangyu, et al.
Publicado: (2021)

Targeting hypoxic tumor microenvironment in pancreatic cancer
por: Tao, Jinxin, et al.
Publicado: (2021)

Is Invagination Anastomosis More Effective in Reducing Clinically Relevant Pancreatic Fistula for Soft Pancreas After Pancreaticoduodenectomy Under Novel Fistula Criteria: A Systematic Review and Meta-Analysis
por: Cao, Zhe, et al.
Publicado: (2020)

MiR-135a biogenesis and regulation in malignancy: a new hope for cancer research and therapy
por: Cao, Zhe, et al.
Publicado: (2020)

The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells
por: Fu, Yibo, et al.
Publicado: (2021)

PRKRA promotes pancreatic cancer progression by upregulating MMP1 transcription via the NF-κB pathway
por: Qiu, Jiangdong, et al.
Publicado: (2023)

Long noncoding RNA GSTM3TV2 upregulates LAT2 and OLR1 by competitively sponging let-7 to promote gemcitabine resistance in pancreatic cancer
por: Xiong, Guangbing, et al.
Publicado: (2019)

MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma
por: Xiong, Guangbing, et al.
Publicado: (2018)

Correction to: MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma
por: Xiong, Guangbing, et al.
Publicado: (2021)

Cancer-specific survival and metastasis in pancreatic mucinous cystadenocarcinoma: A SEER-based cohort study
por: Wang, Ruobing, et al.
Publicado: (2022)

Identification and Validation of Constructing the Prognostic Model With Four DNA Methylation-Driven Genes in Pancreatic Cancer
por: Chen, Guangyu, et al.
Publicado: (2022)

Novel therapies targeting hypoxia mechanism to treat pancreatic cancer
por: Luo, Wenhao, et al.
Publicado: (2021)

Pancreatic head cancer: Open or minimally invasive pancreaticoduodenectomy?
por: Feng, Mengyu, et al.
Publicado: (2019)

Metabolism of pancreatic cancer: paving the way to better anticancer strategies
por: Qin, Cheng, et al.
Publicado: (2020)

MiR-1178 Promotes the Proliferation, G1/S Transition, Migration and Invasion of Pancreatic Cancer Cells by Targeting CHIP
por: Cao, Zhe, et al.
Publicado: (2015)

CHIP: A new modulator of human malignant disorders
por: Cao, Zhe, et al.
Publicado: (2016)

High-resolution Hi-C maps highlight multiscale 3D epigenome reprogramming during pancreatic cancer metastasis
por: Ren, Bo, et al.
Publicado: (2021)

PIM-1 contributes to the malignancy of pancreatic cancer and displays diagnostic and prognostic value
por: Xu, Jianwei, et al.
Publicado: (2016)

Pancreatic panniculitis associated with pancreatic carcinoma: A case report
por: Zhang, Guannan, et al.
Publicado: (2016)

Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review
por: Yang, Jinshou, et al.
Publicado: (2021)

Preclinical models of pancreatic ductal adenocarcinoma: challenges and opportunities in the era of precision medicine
por: Yu, Yiqi, et al.
Publicado: (2021)

Reprogramming of Amino Acid Metabolism in Pancreatic Cancer: Recent Advances and Therapeutic Strategies
por: Xu, Ruiyuan, et al.
Publicado: (2020)

Gemcitabine exhibits a suppressive effect on pancreatic cancer cell growth by regulating processing of PVT1 to miR1207
por: You, Lei, et al.
Publicado: (2018)

Localized Autoimmune Pancreatitis: Report of a Case Clinically Mimicking Pancreatic Cancer and a Literature Review
por: Cao, Zhe, et al.
Publicado: (2015)

MicroRNA-27a (miR-27a) in Solid Tumors: A Review Based on Mechanisms and Clinical Observations
por: Zhang, Jingcheng, et al.
Publicado: (2019)

miR-497 expression, function and clinical application in cancer
por: Yang, Gang, et al.
Publicado: (2016)

Epigenetic reprogramming-induced guanidinoacetic acid synthesis promotes pancreatic cancer metastasis and transcription-activating histone modifications
por: Yang, Jinshou, et al.
Publicado: (2023)

Glutathione S-Transferase Mu-3 Predicts a Better Prognosis and Inhibits Malignant Behavior and Glycolysis in Pancreatic Cancer
por: Wang, Shunda, et al.
Publicado: (2020)

Tumor microenvironment participates in metastasis of pancreatic cancer
por: Ren, Bo, et al.
Publicado: (2018)

Analysis of clinical characteristics and treatment of pancreatic cystic tumors
por: You, Lei, et al.
Publicado: (2016)

GSTM3 Function and Polymorphism in Cancer: Emerging but Promising
por: Wang, Shunda, et al.
Publicado: (2020)

The prospect of serum and glucocorticoid-inducible kinase 1 (SGK1) in cancer therapy: a rising star
por: Zhu, Ruizhe, et al.
Publicado: (2020)

Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer
por: Chen, Yuan, et al.
Publicado: (2021)

The role of histone methylation in the development of digestive cancers: a potential direction for cancer management
por: Chen, Yuan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cp9d2tmtgtv20br0rsd952malb